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Sequential analysis of changes that lead to 
chronic rejection was undertaken in an animal 
model of chronic rejection and obliterative arte-
riopathy. Brown Norway rats are pretreated 
with a Lewis bone marrow infusion or a Lewis 
orthotopic liver allograft and a short course of 
immunosuppression. They are challenged 100 
days later with a Lewis heterotopic heart graft 
without immunosuppression. The heart grafts in 
both groups undergo a transient acute rejection. 
but aU rats are operationaUy tolerant; the heart 
grafts are accepted and remain beating for more 
than 1()() days. Early arterial remodeling, 
marked by arterial bromodeoxyuridine incorpo-
ration, occurred in both groups between 5 and 30 
days during the transient acute rejection. It co-
incided with the presence of interstitial (but not 
arterial intimal) inflammation and lymphatic 
disruption and resulted in mild intimal thicken-
ing. Significant arterial narrowing occurred only 
in tbe bone-marrou'-pretreated rats between 60 
and 1()() days. It was associated with T lympbo-
cyte and macrophage inflammation of the beart 
grqft that accumulated in the endocardium and 
arterial intima and adr'entitia near draining lym-
phatics. There also was loss of passenger leuko-
cytes from the beart graft. up-regulation of 
cytokine mRNA and major histocompatibility 
class II on the endothelium, andfocal disruption 
Of lymphatics. In contrast, long-surviving heart 
gruJ!s from the Lewis orthotopic liver allogruJ! 
pretreated group are near normal and freedom 
from chronic rejection in this group was associ-
ated with persistence of donor major histocom-
patibility class-II-positive hematolymphoid ceUs, 
including OX62+ donor dendritic ceUs. This study 
offers insights into two different aspects of 
chronic rejection: 1) possible mechanisms under-
lying the persistent immunological injury and 2) 
the association between immunological injury 
and the development of obliterative arteriopathy. 
Based on the findings, it is not unreasonable to 
raise the testable hypothesis that direct presen-
tation of alloantigen by donor antigen-presenting 
ceUs is requiredfor long-term, chronic-rejection-
free allograft acceptance. In addition, chronic 
intermittent lymphatic disruption is implicated 
as a possible mechanism for the association be-
tween chronic interstitial allograft inflammation 
and the development of obliterative arteriopathy. 
(Am] Pathol1997, 150:563-578) 
Obliterative arteriopathy (OA), the pathognomonic 
lesion of chronic rejection (CR),1-4 is thought to be 
the result of direct immunological injury to the artery, 
It has been proposed that attachment of lympho-
cytes to the allogeneic arterial endothelium and sub-
sequent endothelial damage create abnormalities 
that trigger intimal myofibroblast proliferation. This 
eventually progresses to arterial luminal narrow-
ing,1-3 
Supported by a grant from the American Heart Association, Penn-
sylvania Affiliate. 
Accepted for publication October 19, 1996. 
Address reprint requests to Dr. A J Demetris. Department of 
Pathology, DiVision of Transplantation, BMST E1548, University of 
Pittsburgh, Pittsburgh, PA 15213 
563 
..::.:> 
-'. 
r: 
t D 
.r" 
K-:~K 
-: 
.- j 
, 
.l 
;~li 
:'.) 
.c", 
:J: 
c 
!l 
-~Df t. ,., 
" '1 til 
~KI 
'-' , 
...... ! 
'r'11 ?~! 
,- J 
r' \, 
C/~ 
I 
I 
I 
564 Demetris et al 
AIP Febmary 1997. Vol. 150, ,'\io. 2 
As CR and OA are difficult to study in clinical 
samples, much of the research comes from small 
experimental animal models that rely on minor major 
histocompatibility (MHC) mismatches between the 
donor and recipient5.6 These animal models and 
some clinical observations? generally support the 
above sequence of events. However, a number of 
basic clinical and some experimental observations 
about OA are not readily explained by that scenario: 
1) OA preferentially involves medium-sized intra-or-
gan muscular arteries over veins, despite an anti-
genically similar endothelium, 2) inflammatory arteri-
tis does not always precede OA, 3) in general, 
pulmonary arteries are less severely affected and 
pulmonary veins are more severely affected than 
corresponding coronary vessels in heart-lung trans-
plant recipients,89 4) the endothelium of affected 
vessels is frequently intact,2,8 5) foam cell OA is most 
common in hepatic allografts,2 6) mechanical factors 
in medium-sized muscular arteries are not ideal for 
lymphocyte attachment and exocytosis, except dur-
ing severe acute rejection, and 7) the reasons for 
reversible, antigen-dependent and irreversible anti-
gen-independent phases of OA are not readily ap-
parent. 10 Several of these observations suggest that, 
in addition to immunological injury, mechanical fac-
tors are important in the genesis of OA. Furthermore, 
mechanisms underlying the continued immunologi-
cal reactivity of CR are poorly understood. 
The discovery of microchimerism in successful 
organ allograft recipients 11-13 and its disappearance 
in recipients with CR13-15 offered possible insights 
into immunological mechanisms underlying this of-
ten indolent form of allograft injury. This contention 
was based on the considerable evidence that natural 
hematopoietic chimerism observed in freemartin cat-
tle 16 or iatrogenically induced hematopoietic chimer-
ism in neonates or adult experiment animals 17-20 
-------__ results in a robust form of graft acceptance. Al-
though other laboratories have confirmed our find-
ings, they have questioned whether the microchi-
merism observed in patients might be an 
epiphenomenon of graft acceptance by some other 
mechanism.21 -23 
In an effort to address questions related to micro-
chimerism, an experimental model of CR was inad-
vertently developed.24 The current analysis of this 
model led us to propose pathogenetic mechanisms 
of CR that contribute to an understanding of the 
association between chimerism and graft accep-
tance and current inconsistencies in the pathogen-
esis of OA. 
Materials and Methods 
Animals and Transplant Procedures 
Details of the operative procedures and immunosup.-
pression protocol were described elsewhere. 24 
Briefly, 200- to 300-g male LewiS (LEW, RH) and 
Brown Norway (BN, RT1 n) rats (Harlan Sprague 
Dawley, Indianapolis, IN) were used as donors and 
recipients, respectively, for all experiments. Liver al-
lografts were placed orthotopically after recipient 
hepatectomy.25 Heart grafts were vascularized het-
erotopically in the abdomen.26 Bone marrow cells 
(2.5 x 108 cells; >90% viable by Trypan blue eXClu-
sion) were washed from the medullary cavity of tibias 
and femurs, processed in RPMI 1640 supplemented 
with 25 mmol/L Hepes buffer, 2 mmol/L L-glutamine, 
50 U/ml penicillin, and 50 p,g/ml streptomycin (all 
from Gibco, Grand Island, NY) and given by intrave-
nous injection into the penile vein.24 
Experimental Design 
BN recipients were pretreated with a LEW orthotopic 
liver allograft (OLTx) or an infusion of LEW bone 
marrow cells (BM) on day 0 and given intramuscular 
injections of 1.0 mg/kg/day Tacrolimus (FK506; dis-
solved in HCO-60 and D-mannitol, Fujisawa Pharma-
ceutical Co., Osaka, Japan) for 14 days starting on 
the day of transplantation and supplemented with 
single injections at the same dose on days 20 and 
27. This treatment regimen after BM or OL Tx pro-
duces hematolymphoid microchimerism for at least 
100 days. Subsequent challenge with a heterotopic 
LEW but not a third-party heart allograft on day 100 
results in graft acceptance for more than 100 days 
without immunosuppression.24 LEW cardiac grafts 
transplanted into recipients given the brief Tacroli-
mus regimen alone are rejected. 24 However, CR is 
observed in the heart allografts after 100 days of 
sdfvival of 8M-pretreated rats but not those pre-
treated with OL Tx. 24 
To serially investigate the changes leading to CR in 
the BM-pretreated group in comparison with the OL Tx-
pretreated reCipients, at least three rats from each 
group with a beating heart allograft were sacrificed 5, 
10, 15, 30, 60, and 100 days after placement of the 
heart. Controls consisted of heterotopic LEW or BN 
heart grafts transplanted iflto syngeneic LEW or BN 
recipients, respectively. At the time of sacrifice, the 
challenging cardiac grafts and the native hearts were 
serially sectioned in a transverse plane across both 
ventricles. Separate pieces were appropriately triaged 
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Table 1. Panel of lmnlllnobistocbemical and Histocbemical Reagents Used /0 Cbaracterize tbe Cbronic Rejection Model 
Histochemical stain 
or monoclonal 
antibody 
R7.3 
OX62 
W3/25 (CD4) 
OX8 (CD8) 
OX33 
ED1 
ED2 
L21-6 
OX6 (HLA-DR) 
alpha smooth muscle actin 
5' nucleotidase 
*Sera-Lab, Crawley Down. UK. 
tDako. Carpinteria, CA. 
Supplier or method 
Sera-Lab* 
Sera-Lab 
Sera-Lab 
Sera-Lab 
Sera-Lab 
Sera-Lab 
Sera-Lab 
Gift of Y. Iwaki 
Sera-Lab 
Dakot 
Kato et al30 
for routine histopathology, immunohistochemistry, and 
cytokine mRNA analysis (see below). 
Routine Pathology Studies 
AI! slides generated from the heart grafts were read 
without knowledge of the pretreatment group or tim-
ing of the sample. The overall severity of inflamma-
tion in the endocardium, pericardium, interstitium, 
and periarterial spaces was semiquantitatively 
graded on a scale of 0 to 4 as none, minirlal, mild, 
moderate, or severe. Arterial alterations, including 
the presence of inflammation, edema, fibrosis, and 
vacuolization of the intima, media, and adventitia 
were graded in the same fashion. All of the arteries 
>80 J.Lm in shortest external diameter present in one 
cross section of the heart allografts at 50 and 100 
days after transplantation were evaluated for the se-
verity of OA. The grading of OA was as follows: none, 
grade 0; minimal, grade 1, < 10% luminal narrowing; 
mild, grade 2, 10 to 25%; moderate, grade 3, 25 to 
50%; moderate/severe, grade 4, 50 to 75%; and 
severe, grade 5, > 75% luminal narrowing. 
Immunohistochemical Studies 
Immunohistochemical staining with a routine indirect 
avidin-biotin complex method27 was used to deter-
mine the phenotype of inflammatory cells infiltrating 
the heart allografts (Table 1). At least two animals 
from each group were examined at each time point. 
An immunoglobulin class-matched nonimmune anti-
bOdy was substituted for the primary antibody in the 
negative controls. As with the routine histopatholog-
ical studies, the immunostalned slides were re-
viewed without knowledge of the pretreatment regi-
men or timing of the sample. The relative number of 
Positively stained cells in endocardium, pericardium, 
interstitium, and perivascular spaces was semiquan-
Labeling specificity 
T lymphocytes with af3-receptors 
T lymphocytes with 'Y&-receptors and dendritic cells 
T helper subset, all macrophages 
T cytotoxic-suppresser subset 
B cells 
Circulating macrophages 
Tissue macrophages -~ ___ _ 
Invariant chain of MHC class II of most rat strains, except BN 
la common part determinant 
a-Smooth muscle isoform of actin found in smooth muscle 
Lymphatic endothelium and lymphocyte subsets 
titatively scored for each antibody on a scale of 0 to 
4, as descnbed above. 
The monoclonal antibody L21-6, which reacts with 
donor (LEW), but not recipient (BN) MHC class II anti-
gen, was used to differentiate donor from recipient 
cells28 The number of donor MHC class 11"'- cells was 
determined by selecting a representative field and 
counting the L21-5+ cells at X40 magnification. Dou-
ble immunofluorescent labeling with Cy3 (indocarbo-
cyanine)-conjugated L21-5 and ED1, ED2, or OX52 
reacted with fluorescein isothiocyanate was used to 
determine the phenotype of donor MHC class 11+ he-
matolymphoid cells present in the heart grafts.29 
The number of cells in the arterial wall undergoing 
DNA synthesis was determined by pulsing the rats 1 
hour before sacrifice With an intravenous injection of 
50 mg/kg bromodeoxyuridine (BrdU) and localizing 
the labeled cells with anti-BrdU monoclonal anti-
body, as above. Separate counts were recorded for 
the intima, media, and adventitia of all intramyocar-
dial arteries for at least two animals at each time 
pOint. Only vessels cut in cross section were in-
cluded in the counts. 
Histochemical staining for 5'-nucleotidase activity, 
which reacts with lymphatic but not with arterial, 
venous, or capillary endothelium,30·31 was used to 
highlight the lymphatic channels. 
Cytokine mRNA Analysis 
Total RNA was extracted from a portion of the heart 
allograft using the RNAzol B modified method32 and 
the concentration determined by spectrophotometry. 
cDNA was synthesized by transcription from RNA in 
the presence of human placental RNAse inhibitor, 1 
nmol/L deoxynucleoside triphosphates, oligo-dT 
primer. murine leukemia virus reverse transcriptase, 
and reverse transcriptase buffer. The reverse tran-
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Table 2. Primer Sequellces of C:vtokilles l'sed 10 Delecl C)'lokill£' mRX4 ill Tissue Samples (If ChallellRe Cardiac :DK:fD:·I-K~DID 
KKtllograftsI~ "; J 
Primers Primer sequence Product size-:f~D;; 
(r)IL-2 5' ACG cn GTC CTC cn GTC AAC 
3' CAG ATG GCT ATC CAT CTC CTC 
5' ACA GCG ATG ATG CAC TGT CAG 
3' ATG GTC nG GTC cn AGC CAC 
5' TGT CT A CTG AAC nc GGG GTG 
3' GAG GCT GAC TIT CTC CTG GT A 
5' CAA GGC ACA CTC An GAA AGC 
3' CTC GAA cn GGC GAT GCT CAT 
5' n A cn GGG nG CCA AGC cn 
3' Gn CAC AGA GAA GCT CAG T 
""'M'''' ---~~~~D 401 bp 
(r)IL-6 
(r)TNF-a 
(r)IFN-y 
(r)IL-10 
(m)I3-Actin 5' nc TAC AAT GAG CTG CGT GTG 
3' nc ATC GAT GCC ACA GGA nc 
337 bp 
365 bp 
297 bp 
49Sbp 
627bp 
r, rat; m, mouse: TNF, tumor necrosis factor; IFN, interferon, 
scriptase polymerase chain reaction (RT-PCR) of the 
resulting cDNA was performed according to the 
method of Brenner et al33 with some modifications34 
using [32PjdCTP-labeled primers specific for the rat 
cytokines interleukin (IL)-2, IL-6, IL-10, interferon-y, 
and tumor necrosis factor-a (Table 2). Amplification 
was carried out for 30 cycles on a model 480 thermal 
cycler (Perkin Elmer, Norwalk, CT), As an internal 
control for RNA quality, all samples were also as-
sessed for f3-actin. For negative controls, PCR am-
plification was performed with sterile water substi-
tuted for cDNA. PCR products were analyzed by 
electrophoresis in 2% agarose gels and visualized 
by ethidium bromide staining. The product of ampli-
fication was also electrophoresed on an 8% poly-
acrylamide gel, which was dried and analyzed by 
autoradiography. The amount of radioactivity incor-
poration in the PCR product was counted using a 
f3-scan. The results were normalized to f3-actin and 
expressed as a ratio of cytokinelf3-actin. 
Statistical Analyses 
The results of continuous variable measurements are 
presented as the mean ± SO or SEM, and the Stu-
-----dents t-test was used for the statistical comparison 
of groups. The Mann-Whitney U test was used for a 
comparison of the ordinal noncontinuous variables, 
such as the severity of inflammation, OA, and immu-
noperoxidase staining. The level of significance for 
both tests was set at a P value of 0.05. 
Results 
Routine Histopathology and Lymphocytic 
Infiltration of the Heart Allografts 
Serial routine and immunohistological studies were 
carried out to follow the evolution of changes leading to 
CR and OA in the BM-pretreated rats in comparison 
with the CR-resistant OL T x-pretreated recipients. For 
convenience of presentation, the time after transplan-
tation was broken down into the early period extending 
from 5 and 30 days and the late period encompaSSing 
the 60- and 1 ~l-day time points. 
During the early time period, the challenging car-
diac allografts underwent an acute rejection crisis. It 
peaked between 5 and 15 days, regardless of the 
pretreatment group (Figure 1, A-C) and was char-
acterized by mononuclear inflammation somewhat 
concentrated in the endocardium, pericardium, and 
perivascular spaces, with more patchy interstitial in-
volvement. The quantity of inflammation was signifi-
cantly less in the OL Tx-pretreated rats (Figure 2) 
than in those primed with BM for all time points after 
transplantation.-In general, the lymphocytic infiltrates 
seen early after transplantation in both groups were 
similar in composition. They consisted predomi-
nantly of af3-receptor-positive T cells, with the CD4+ 
subset predominating over the CD8+ cells and a 
minimal number of OX33+ B cells (data not shown). 
However, the number of ED2+ tissue macrophages 
significantly decreased in the BM-pretreated rats, 
whereas the number of these cells remained near 
normal in the OLTx-pretreated rats during the early 
time p~riod (see below). 
The mononuclear inflammation persisted in the 
heart grafts from BM-pretreated recipients (Figures 
1, 0 and E, and 2) but not in the OLTx-pretreated rats 
during the late phase. In the former, the inflammation 
eventually coalesced into nodular aggregates in the 
endocardium, pericardium, and perivascular spaces 
of blood vessels and lymphatic channels at 60 and 
100 days. These had routine ,histopathological and 
immunohistochemical similarities to Quilty lesions in 
humans35 (Figure 1 F), which are mostly circum-
scribed subendocardial nodular aggregates of Iym-
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Figure 1. A to E: Seql/clltial histopatholop,iw! appearclllce of the chal/enp,e heart allografts at 5. 10. 15. 60. and 100 days after transplantation. 
respectin'/]', 77.,,' le(i side of eacb pbotomicrop,rap!> l' fmm an OLTx-pretreated reCipiellt alld tbe rigbt side g~D from a 8M-pretreated rat. Sate the 
transielJl illJlammtlti(1I/ ill the OlT.-r-pretreated rats. bl tbe 8M-pretreated rats. tbe illjlammati(JIl coalesced illto subendocardial aggregates by 60 days 
after trtlllsplallllllioli. F: HIgh pOII'er ( x 30m ['ieu' of (",d"care/wl illftltrate in a B.11-pretrmted rat 100 dan after trtlllspkmtation. stained for CD8 
(left sillel alld CD4 (rig!>t side) IIsillg (/II illdire..-t imlllllllo!JCmxidase pmcedure Sote tbe predamillance of tbe CD4+ T cells in the elldocardial 
~vmphoid aggregates alld silllliarities 10 Qllilt)' leSIOIIS ill hllmall elldomyowrdial bIOpsies .. lIagllijicalioll. X 18 (exapl for Fl. 
phocytes detected in endomyocardial biopsies. Sim-
ilar to the aggregates detected in humans, the 
endocardial infiltrates in this study were predomi-
nantly composed of aj3-receptor-positive T lympho-
cytes, with CD4 + cells outnumbering CD8 + cells by 
3:1 to 4:1. CD8+ cells were evenly distributed 
throughout the lesions, and occasionally small nod-
ules of OX33 + 8 cells were detected. The cardiac 
interstitium showed an increase in the number of 
n~-receptor-positive T cells. 
Cytokine mRNA Analysis of Heart Allografts 
Analysis of the cardiac allografts for IL-2, IL-6, IL-10, 
tumor necrosis factor-a, and interferon-), mRNA pro-
vided additional important functional information 
about the immunological milieu of the heart allografts 
(Figure 3). Early after transplantation, in both the 
OLTx- and 8M-pretreated rats, increased message 
for interferon-)" tumor necrosis factor-a, and IL-10 
correlated with the mononuclear inflammation and 
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Figure 2. A scatter plot 0/ the ol'erall seI-Ieri~v of injlammation shou's 
that the B.H-pretreated challenge grafts u-ere more Set.'f!rely in/lamed. 
The set.'eritv of injlammatio" U'aS scored at four sites (endocardial. 
pericardIUm. perivascular areas. and interstitium) in each graft. Two 
to jiJl/r iJrafts from B.lf-pretreated (e) or OLTx-pretreated (G) recipi-
ellts were ana~lDzed at each time point. 
neo-expression of MHC class lion the vascular en-
dothelial cells (see below) IL-2 and IL-6 were also 
increased, but to a lesser extent. Late after trans-
plantation, the persistent allograft inflammation in the 
BM-pretreated rats correlated with the presence of 
cytokine mRNA and up-regulation of class II MHC on 
the vascular endothelium. In contrast, cytokine 
mRNA largely disappeared from the cardiac allo-
grafts of OL Tx-pretreated recipients by 60 days and 
remained undetectable throughout the period of fol-
low-up. 
Phenotype and Origin of Infiltrating 
Macrophages in the Heart Allografts 
Recipient macrophages play an important role in the 
development of CR and OA,5 whereas donor den-
dritic cells (DCs) have been detected in microchi-
___ meric recipients 13.36 with uncomplicated long-term 
-'Courses. Therefore, we thought it was important to 
determine whether differences in the macrophage 
and related cell populations existed between the two 
groups, which might be related to the development 
of CR. 
The changes in macrophage populations mirrored 
the inflammatory pathology within the heart' allo-
grafts. In both groups during the early period, the 
number of spindle-shaped ED2+ tissue macro-
phages decreased, whereas the number of infiltra-
tive ED1 + macrophages and OX62+ DCs increased 
compared with the number of these interstitial cells in 
a normal heart. By day 10, there were significantly 
more ED2+ tissue macrophages remaining in the 
A 
BM-pretreated 
B 
OL TX-pretreated 
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Figure 3. S()lIlhern hlot and hyhridization of RT-PC'R products ob-
tainedfrom assaysforeytakine mR\A ill the challtmge heart allografts 
0/ BM-pret,mted recipiellls (A) mid OlTx-pretreated rats (S) at vari· 
ous limes after transplantation. ,\late the waning signals for mteifer. 
on·y. tumor necrosis/actor-a. IL·6. alld JL-10 in the challellge heart of 
the OLT.r:-pretreated rats and the persistent message for these cytokines 
inlthe challenge heart grafts of the BM-pretreated recipients. C: Semi· 
quantitative analysis (see Materials mid Methods) of cytokine mRNA 
let'f!ls. based on a comparison to f3-actin levels ill the same tissue. The 
top half of the figure represe,lfs the BM-pretreated recipiellls and the 
bottom halfisfrom the OLTx-pretreated rats. Again. note the difference 
ill cytokine message hetu-eell the two groups, pa,ticularly late after 
transplalliafion. 
heart grafts of OL Tx-pretreated recipients (Figure 4) 
and a trend toward fewer ED1 + infiltrative macro-
phages compared with the 8M-pretreated recipients, 
During the late phase after transplantation the in-
flammation disappeared from the heart grafts of 
OL Tx-pretreated rats. The macropr..age population in 
this group was similar to that seen in the interstitium 
T 
I , 
I 
• BM-pretreated 
o OL Tx-pretreated 
3 
* * ~ 
't: 
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000 000 000 
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~ •• •• ••• • •• ••• • •• 
.::: 
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Days after transplantation 
* peO.05 BM vs OL Tx-pretreated, Mann-Whitney U test. 
Figure 4. A scatter plot of the relative number of £Dr interstitial 
macrophages present in the challenge allografts ofOl Tx-pretreated (0) 
and BM-pretreated (.) recipients during the earl)' time period. Note the 
rapid decrease in the number of these cells ill the B.W-pretreated rats 
but not in the OLTx-pretreated reCIpients 
of a normal heart. It consisted of numerous spindle-
shaped ED2+ tissue macrophages and fewer ED1 + 
Infiltrative macrophages. There was no arterial inti-
mal macrophage infiltration. In contrast, there were 
significantly more ED1 + infiltrative macrophages 
and fewer ED2+ tissue macrophages in the heart 
grafts of 8M-pretreated rats compared with the 
OL Tx-pretreated rats. These ED1 + infiltrative macro-
phages were scattered throughout the interstitium 
and formed cuffs around the adventitia of arteries 
that showed intimal thickening typical of OA (see 
below). The increased number of OX62+ DCs in the 
8M-pretreated rats were concentrated amid the lym-
phoid aggregates. In addition, ED1 + macrophages 
and occasional OX62+ DCs also appeared in the 
intima of arteries affected by OA in 8M-pretreated 
rats at 60 and 100 days. 
The number of donor MHC class II" (L21-6+) in-
terstitial hematolymphoid cells rapidly decreased 
during the early phase in the 8M-pretreated rats. 
There was only a transient decrease in these same 
cells during the early phase in OL Tx-pretreated re-
cipients (Figure 5). During the late period in the 
8M-pretreated rats, donor LEW MHC class 11+ inter-
stitial cells disappeared from the heart grafts. They 
were still easily detectable in the OL Tx-pretreated 
recipients, even 100 days after transplantation of the 
heart allograft (Figure 6) 
Double immunofluorescent labeling was used to 
determine the phenotype of the L21-6 + spindle-
shaped interstitial cells remaining in heart allografts 
at 100 days. In the OL Tx-pretreated recipients, the 
majority of donor class II + cells were ED2+ tissue 
macrophages (Figure 6C) with occasional ED1 T in-
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Days after Transplantation 
Figure 5. The number of donor L21..o celWhigh-power field (HPF) ill 
the cardiac allografts at various times after transplantation. 'P < 005 
for R\f \'ersus OLTx-pretreated recipients (Student 5 t-test). 
filtrative macrophages. L21-6+ /OX62+ donor DCs 
were also clearly detected (Figure 60), although they 
were fewer in number than the ED2+ macrophages 
and primarily located in the adventitia of arteries and 
in the endocardium and pericardium. L21-6 staining 
of the heart allografts from the 8M-pretreated recip-
ients at 100 days showed only endothelial positivity 
(Figure 6A); no double labeling of ED1, ED2, or OX62 
cells was detected in this group. 
Donor Hematolymphoid Cells in the 
Recipient Skin and Liver Allografts 
We next determined whether donor MHC class 11+ 
cells were also present in the skin and in the original 
allograft. In the liver allografts, there were usually 
more than ten L21-6+ cells per portal triad at 200 
days after OL Tx, which was 100 days after heart 
graft placement. Three to six L21-6 + cells were de-
tected around each terminal hepatic venule. The 
biliary epithelium and vascular endothelium were 
L21-6-. In the recipient skin 100 days after heart 
transplantation, L21-6+ cells were detected around 
papillary dermal capillaries, in the adventitia of der-
mal arteries, and in the perineural space of OL Tx-
pretreated reCipients. L21-6+ cells were not de-
tected in the skin of the 8M-pretreated rats. 
Sequential Arterial Pathology and 
Remodeling Kinetics 
We next focused on the documentation of sequential 
artenal changes leading to CR and OA in the 8M-
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Table 3. Comparison of the Severity of Obliterative Arteriopathy in Challenge Allografts at 60 and 100 Days after 
Transplantation 
Days after Number of Number of Average grade Percent of arteries 
Treatment transplantation animals arteries scored of lesion with disease 
OLTx 60 3 22 0.27 ::!: 0.12* 23% 
BM 60 5 37 1.19::!:O.29 46% 
OLTX 100 6 42 0.19 ::!: 0.09** 14% 
BM 100 8 63 1.11 ::!: 0.18 50% 
Isograft controls did not show any significant OA and therefano, are not included in this table. 
*P = 0.03, Mann-Whitney U test for OL Tx versus BM at same time point. 
**P = 0.0004, Mann-Wrlitney U test for OLTx versus BM at same time point. 
pretreated group. These were compared with the 
changes seen in the CR-resistant, OL Tx-pretreated 
rats to determine whether the differences observed 
could lead to a better understanding of OA develop-
ment. 
The arterial pathology observed during the early 
phase in both the BM- and OL Tx-pretreated rats was 
similar (Figure 7). On day 5, when focal ihflammation 
and up-regulation of MHC class II were seen in the 
interstitium, edema and inflammatory cells first ap-
peared in the adventitia of intramyocardial arteries, 
The media and intima were relatively unremarkable 
at this time, with the latter showing flattened, inac-
tive-appearing endothelial cells, On day 10, the ad-
ventitial edema and inflammation increased, and 
medial edema and disintegration of individual medial 
myocytes appeared. The arterial endothelium be-
came hypertrophied (Figure 7B) and MHC class 11+ 
at this time. By day 15, subendothelial intimal edema 
appeared and the media assumed an edematous, 
loose, disorganized appearance, In contrast to acute 
vascular rejection, there was no intimal inflammation 
observed in any of the animals. 
During the late phase, obvious differences ap-
peared in the arterial pathology between BM- and 
OL Tx-pretreated recipients (Table 3). In BM-pre-
treated rats, the mild intimal abnormalities noted dur-
ing the early phase worsened or progressed to se-
vere OA by 60 and 100 days (Table 3), with continual 
inflammation of the adventitia, Arteries 100 to 300 
J..l.m in diameter were most often and most severely 
affected, In general, there were two types or stages 
of OA lesions in the BM-pretreated rats, which were 
similar to those seen in humans.2 One consisted of 
an intimal accumulation of ED1 + macrophages that 
was intermixed with a-smooth muscle actin-positive 
myofibroblasts, and some CD4 + and CD8+ T cells 
(Figure 7, F and G). In addition, rare OX62+ dendritic 
cells could also be detected, similar to humans, 1 The 
neointimal cells were usually underlying an intact but 
hypertrophied endothelial layer showing expression 
of donor LEW MHC class II antigens. The other type 
or stage of OA lesion consisted of intimal thickening 
associated with an increased number of a-smooth 
muscle actin-positive intimal myofibroblasts with 
fewer ED1 + foam cells and rare T cells, In both 
lesions, the media was thinned and focally traversed 
by ED1 + macrophages, presumably coming from a 
cuff of ED1 + adventitial macrophages. 
OLTx-pretreated rats did not exhibit these arterial 
lesions, However, occasional arteries from animals in 
this group showed disorganization of medial myo-
cytes and mild intimal thickening that was more se-
vere than the changes seen in the LEW-LEW isograft 
controls (Table 3). 
Quantitative Analysis of Arterial Wall DNA 
Synthesis 
Because the intimal thickening in OA involves the 
proliferation of intimal myofibroblasts,2 BrdU labeling 
was used to sequentially study the kinetics of arterial 
remodeling in this model. It showed that the onset of 
arterial cell proliferation coincided with the mural 
edema and disorganization of medial myocytes de-
tected during the early phase on routine microscopy, 
It occurred before there was any detectable arterial 
intimal inflammation (Figures 7H and 8), Compared 
with normal, nontransplanted hearts in which arterial 
BrdU+ cells are rare, increased BrdU labeling was 
first observed in the adventitia of arteries at day 5, 
Figure 6. A: L21-6 ,mm'/lwpenmdase stain uf challenRt' alluwafts fur dOllar .\fHC-c1as5-11-poslltt¥! ceiL, 100 dars after trallsplamall(11/ '" a 
BM-prel"'ated reclplett!. Sole Ihe postlitJ" stal" 0" (mdothe/wl ceIL, of an al1et)' mlidll" affected by 004 (arrow) MaWlificalio1l. x 120. B: The same 
L21-6 imm'lI/operoxid{lse stal" for delllor MHC-c1ass-ll-postlit<' cdls III the (hal/en"" al/oRrafl of an OLTx-prelreated rat shou¥!d l1umerous postlil'e 
bemato/)'mphoul ceiL" 1l-hen'tlS the al1alal ""dothdlum u'as L21-6 n<'Ratlt¥! a7ld unaffected hI' OA (arrow). Mag1lif,catlo1l. x 120. C: Dot/ble 
Imm,mojlt/ort'scett! l(/bdiI1Rft>r L21-6( red C)3) alld ED2(greelljl,wrescetll isothiocytlllatel 11lthe chalienRe al/ograftu/{lll OLT.,·-pn'lreated reciplem 
sbouoed thtll m{/lty of Ihe demur hematol)'mphold cells prese1lt In the oTRal1lloere EDr tissue mticrophllRes (curved arrows) .HaWliflcalton. X 1000. 
0: Double Immtmujluorescelltlllheling for L21-6 (red C:1'3) alld OX62 (Rn't'rl jluoresceill isuthiocvanate) shou¥!d rare dOtlblt'-pusttlue (.wl/Oll') cells 
(arrow). B\', hlood ,,'sse! ,lItignificalioll. X J(XX) 
---
-"'{ 
.. --:", 
--
! 
• .. 
c 
.. ) 
'::"j 
:): 
, ' 
\ 
. , 
., \ 
<:" 
<I ' ' 
I, ~I 
-I; 
;;i 
D;;~l 
,,,'" 
,." 
," 
(' ) 
c., ~ 
(/-:'<; 
572 Demetris et al 
AIP Ft'lm/ary 1997. Vol. 150. .Vo. 2 
Figure 7. Sequf?llIial arterial alteralions in a RH-pretreated rat. A: 011 day 5. the arterial alteratiolls were fimil .. " tu ad~De"titial i'Ulammalion and 
"dema Note thejiattened elldotbelial cells. B: On day 10. tbe elldothelial cells assumed a hypenropbied appearance mid lIecmsis ofilldil'idllal medial 
myocytes was seen. H&E; magnificatioll. X 200. C: 0" day 15. thi' elldothelial cells became mure hypertropbied. sllivlldutbelial edema appeared. and 
_______ the medial myocytes showed a disorgaII ized appearallce. He-£: magnificatiull. X 20U D: 011 day 30. some mcuo";;:al/(JII uf l'lldotbelial cells U'aS seen. 
--m,d the medial and advellfitial cballges persisted. H&E: magllification, X 100. E: On day 60. ltltimal ilifiltratiull /Jl' I)'mpboc)'tes and macropbages 
became appare1lt. Note also Ihe persistem adl'('llfilial cbanges H&E; magllificati0,JI, X 100. F: On day lOU I-.D1+ macruphages (arrOW) cuffed the 
advelllilia alld traversed the media uf affected arteries. /PEXfor EDl; magllificalia'l. X 1OV. G: lhese i'ifiltratiee macruphages ll'('re foulld illlennixed 
ll'ilh a-smooth muscle actiupusilll'e cl!!1s in the thickened illlima. !PEX/ora-smooth muscle aClill: magnificatiou. X2()O. H: BrdL' labelillg 0/ arteries 
from challenge grafts at 10 da)s after tTallSplan/aliu/l IPEX/ur BrdU; magnification, X 200 .. Vute the presellce o[pusitll'e cells, evell u·,thout atly 
",,'dence 0/ arterial injiammatlOl/. I: Bv 100 days after transplalliatiol/ 0/ the chal/enge grafts. the /lumber of Hrd[ ~ cells itl the intima markedly 
increased This increased illli",al labeli"g u'as t)pical of the late, progressil!e pbase o/GA IP£l(for BrdU; mafillifieatioll. X 200. 
which then remained at high levels for 100 days, An 
increase in BrdU+ cells in the media did not occur 
until day 15, whereas those in the intima slowly in-
creased during the early phase. Interestingly, a tem-
porally similar pattern of increased BrdU labeling 
was seen in the isograft conlrols during the early 
phase. However, the overall magnitude of the re-
sponse in the isografts was significantly less than 
seen in allograft recipients (data not shown) 
Late after transplantation, the number of BrdU+ 
intimal cells markedly increased in the BM-pre-
treated rats at 60 and 100 days (Figure 71). The 
population of stained cells consisted of an admixture 
of endothelial cells, myofibroblasts, and inflamma-
r 
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Figure 8 . • 'I·/lmber of celL, ill the intima. media. and [ldt'l!1ztitia ~1"fl­
thesizillg DX4 EBrd[D~ I at !'ariO/lS times after tra1lSplillitation in BK~f­
pTr!tTr!ated rats ( 11 = 2 at each time pointl. 
tory cells. In contrast, BrdU labeling decreased to 
isograft control levels in the OL Tx-pretreated rats, 
which was limited to a rare positive cell. 
Sequential Lymphatic and Microvascular 
Pathology 
Some of the arterial changes described above are 
similar to those seen after lymphatic obstruction 
alone.37 In addition, lesions similar to OA are seen in 
arteries at the base of ulcers and in arteries feeding 
carcinomas that have invaded lymphatic channels 
(personal observation). We therefore wondered 
whether lymphatic channels were disrupted in the 
heart allografts and whether the peculiar anatomical 
distribution of the lymphoid aggregates was related 
to the lymphatic drainage of the heart. Therefore, 
5'-nucleotidase enzyme histochemistry was used to 
highlight the lymphatic channels. 
In the normal heart, 5'-nucleotidase stained a net-
work of small. capillary-sized lymphatic channels be-
tween cardiac myocytes. Positively stained endothe-
lial cells also lined smaller and larger thin-walled 
lymphatics seen near the pericardial surface and 
immediately subjacent to the endocardium. 
Early after transplantation, in both the BM- and 
OLTx-pretreated recipients, the aggregates of 
mononuclear cells that first appeared in the endo-
cardium, pericardium, and adventitial space of arter-
ies localized near larger thin-walled lymphatic chan-
nels. As the inflammation intenSity increased, 
infiltration and damage to the wall of lymphatic chan-
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Figure 9. A: Early after transplantation. staining for S -nucleotidase 
showed disruption of the thin-walled (vmphatic channels by intoading 
mononuclear cells (arrow) that formed aggregates near these vessels 
(10 days after transplantation in a 8M-pretreated rail. S -Nucleotidase 
stain, magnification. X 300. B: Late after transplantation, the endo-
cardial infiltrates displaced or focal(y destroyed tbe subendocardial 
(vmpbatic cbamzels. Note tbe lack of lympbatic t'l!ssels uoitbin tbis lesion 
(arrows) but intense labeling just subjacent to the endocardial sUrface 
(60 days of transplantation). S -Nucleotidase stain: magnification. 
X 150. 
nels were easily recognized (Figure 9A). The edem-
atous adventitial space of arteries during this time 
also showed dilated and/or disrupted lymphatic 
channels. In addition, medial myocytes, intercalated 
disks between cardiac myocytes, and endothelial 
cells of arteries with medial edema (see below) ac-
quired smudgy staining for 5'-nucleotidase. In the 
microvasculature, there was up-regulation of MHC 
class II on the endothelial cells, which was distinct, 
diffuse, and sustained in the BM-pretreated rats. In 
contrast, microvascular class II MHC up-regulation 
was mild, focal, and transient in OLTx-pretreated rats 
during this time. 
The endocardial infiltrates that developed late 
after transplantation were situated near the 5' -
nucleotidase-positive subendocardial lymphatics. 
The interstitium within these inflammatory cell ag-
gregates was either devoid of lymphatic channels 
or showed disrupted ones (Figure 9B). The same 
was true for the pericardial and perivascular lym-
phoid aggregates. Staining for 5' -nucleotidase in 
the grafts from OL Tx pretreated rats and LEW 
isografts were similar to a normal heart, except for 
disruption of lymphatic channels in the pericardial 
tissue. In addition, there was continuous up-regu-
lation of MHC class II on the microvasculature of 
BM-pretreated recipients but not on those given 
OLTx. 
A summary of the overall results comparing the 
OL Tx- to the BM-pretreated allograft recipients is 
shown in Table 4. 
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Table 4. Comparison of fh" Findil/gs in the Challenge Cardiac Allograji and Recipient of OLn:- and B.l1-Pretreated 
Recipients 
Characteristic 
Acute rejection changes 
Early-phase arterial changes 
Persistent inflammation at 100 days 
Donor reactive lymphocytes and cytokine 
mRNA in challenge allograft at 100 days 
Donor hematolymphold cells at 100 days (see text) 
In challenge allograft 
In recipient 
In original graft 
Obliterative arteriopathy at 100 days 
NA not applicable 
Discussion 
The results presented here offer insights into two 
different aspects of the study of CR: 1) possible 
mechanisms underlying the persistent immunologi-
cal injury and 2) the association between immuno-
logical injury and the development of OA. First, how-
ever, a practical observation deserves special 
emphasis: assessment of long-term cardiac allograft 
survival in experimental animals must include a de-
tailed histopathological assessment of the graft. As 
this study has shown, ignoring the histology can 
result in an erroneous assumption of tolerance when 
the graft is chronically rejecting. 21 .22 Functional do-
nor specificity of graft-infiltrating lymphocytes cul-
tured from the chronically inflamed hearts from the 
8M-pretreated group was shown in primed lympho-
cyte testing assays. Lymphocytes could not be cul-
tured from the OL T x-pretreated heart grafts at 100 
days (data not shown). 
The observation that protection from CR was seen 
only in OL Tx-pretreated rats offers some insight into 
the possible mechanisms underlying the persistent 
immunolo'dical injury in 8M-pretreated rats. In isola-
--------------!i<:m, this observation seems to support the conten-
tion that the allograft itself provides the most impor-
tant tolerogenic signaI.21.22.38 Indeed, it would be 
easy to envisage the accumulation of anergic T cells 
produced by circulation through the large allogeneic 
liver devoid of antigen-presenting cells38 However, 
when alloantigen expression is limited to hepatic 
parenchymal cells using hepatocyte-specific pro-
moters in transgenic mice, activation-induced lym-
phocyte deletion is incomplete and the livers remain 
chronically inflamed39 Furthermore, neither pretreat-
ment with a donor heart allograft,24 nor the heart < 
graft itself in the 8M-pretreated group, is able to 
provide protection from CR, despite the presence of 
significant non immunogenic parenchymal tissue. 
Yes 
Yes 
No 
No 
OLTx 
Pretreatment 
Yes 
Yes 
Yes 
Yes 
Yes No 
-
BM 
Yes Minimal to absent 
Yes NA 
Mild, residuum of early phase Severe, progressive 
----
Thus, it is not unreasonable to suggest that the so-
called hepatic tolerogenicity and protection from CR 
lies in a property other than the large component of 
parenchymal cells. 
In this study, persistence of the donor hematolym-
phoid cells, including the highly immunogenic donor 
Des,40 was associated with freedom from CR. In-
stead of parenchymal tissue delivering a tolerogenic 
signal, the grafted liver may provide an especially 
good microenvironmental niche for delivering and/or 
sustaining donor hematopoietic stem cells.4142 Un-
fortunately, the experimental design of this study 
precludes a direct answer to the question of whether 
parenchyma or hematolymphoid cells is the most 
important factor. In addition, determining whether 
the liver appties other selection pressures to the 
recipient T cell repertoire will require additional 
study. However, our conclusion at this time is in 
agreement with Maeda et al,43 who suggest that the 
tolerogenic state induced by the graft parenchyma 
or nonhematolymphoid tissue is less robust than that 
seen with hemopoietic chimerism. 
These results are also consistent with allogeneic 
tolerance being a multi-level phenomenon.4445 
There is no question that many manipulations can 
prdfong allograft survival. 2122 However, the differ-
ence in the in vivo level of unresponsiveness seen 
with chronic exposure to donor parenchymal ver-
sus hematolymphoid cells may account for the 
persistent inflammation that leads to CR. There-
fore, it is not unreasonable to raise the testable 
hypothesis that direct presentation of alloantigen 
by mobile donor antigen-presenting cells, which 
have direct access to the entire recipient lymphoid 
system, are required for long-term tolerance with 
freedom from CR. Considering the complexity of 
the immune system, it is unlikely that allo-tolerance 
will ever be attributable to a single cell type. Nev-
I 
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IMMUNOLYMPHATIC THEORY OF CHRONIC REJECTION 
1m m uoological Factors 
(antigen dependent) 
C R -resista n t 
(Robust tolerance) 
Art e r ia I Wall Ed e m a 
oless SMC growth inhibition 
-m ore matrix production 
-more SM C proliferation 
+ 
-Persistence of 
donor APC 
-R esolution of 
inflammation 
-? Direct Presentation 
CR-prone 
(Weak tolerance) 
-Influx of recipient A PC 
-Persistent inflam m ation 
• ? Indirect Presentation 
-A Itered leukocyte 
------
trafficking through organ 
Figure 1 O. Schematic representation of the immWlOil'mphatic theory oj chronic rejection. This is a hypothesis, "Nch u'as raised as a result vJ the 
oiJst.'n'tltlUlls made in IhlS e.\pt'rimellw! mudd 
ertheless, these observations would explain why 
immunologically active hematolymphoid cells 
have historically been the best source of tolero-
genic alioantigen. 19.20 .43.46 Future studies will 
have to closely monitor for the development of CR 
and simultaneously exclude the possibility of do-
nor hematolymphoid cell involvement. 21,22 
Two important inter-related observations in this 
study provide a potential insight about the associ-
ation between immunological injury and the devel-
opment of OA: 1) arterial remodeling begins be-
fore there is any noticeable intimal inflammation 
and 2) OL Tx-pretreated rats experience the early 
phase, which results in mild intimal thickening, but 
they are spared from the later phase when OA 
worsens or progresses. These observations sug-
gest that factor(s) associated with acute rejection, 
other than direct lymphocytic damage to the allo-
geneic endothelium, can contribute to the devel-
opment of OA. 
Based on the following evidence, we would like 
to raise the possibility that alterations in the trans-
port of cytokine-rich lymph fluid within the graft 
can importantly contribute to the development of 
OA (Figure 10) Studies done long ago have shown 
that lymphatics from a renal allograft eventually 
reconnect to recipient lymph vessels within iOta 
14 days,47 unless disrupted by rejection During 
acute rejection, there is an increased production 
of lymph fluid and disruption of the lymphatiC mi-
crovascular endothelial junctions, which retards 
lymphatic flow.47-so The same is true of recurrent47 
or late rejection episodes; Ruggiero et al 51 showed 
total cessation of lymph flow from late-rejecting 
lung allografts. In this study, lymphatic disruption 
is observed in both groups during the early stage. 
The arterial wall changes during this time are rem-
iniscent of those seen after lymphatic obstruction 
alone. 37 Thus, impaired transmural migration of 
lymph formed by high-pressure arterial pl>!sations2 
may ~ccount for the arterial wall edema seen in 
this study. 
The worsening or progression of OA seen during 
the late phase in the BM-pretreated recipients was 
most clearly associated with infiltration of the allo-
graft by T lymphocytes and ED1 + macrophages. 
Interestingly, the inflammatory cell aggregates ob-
served in the allografts with CR during the late 
phase localized near draining lymphatics, which 
were also focally disrupted in areas of fibrosis. In 
addition, the inflammatory cells present in the ar-
terial intima appeared to invade from the adventitia 
via the media. These findings, along with contin-
ued segmental medial edema of affected arteries, 
suggests that interstitial fibrosis and subsequent 
focal and/or intermittent lymphatiC disruption also 
contributes to the late phase of OA progression. 
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Lastly, there are morphological and immunohisto-
chemical similarities between the inflammatory cell 
aggregates seen in this study and Quilty lesions53-56 
and portal lymphoid aggregates in patients with 
chronic hepatitis.57 The nodal-like architectural ar-
rangement and regional up-regulation of microvas-
cular class II MHC suggest that these aggregates 
serve an antigen processing and presentation func-
tion. Although several clinical studies have shown a 
correlation between Quilty lesions and acute rejec-
tion or CR,54.58-62 a direct causal relationship be-
tween the two has not been established. Neverthe-
less, this animal model may serve as a useful tool to 
study Quilty lesions. 
A summary of the key observations in this study, 
the questions they raise, and our overall hypothesis 
is schematically illustrated in Figure 10. We do not 
mean to replace or discount the notion that direct 
intimal arterial injury can lead to OA. Instead, com-
plementary pathways are suggested that incorpo-
rate both immunological and mechanical factors into 
the pathogenic scheme. 
References 
1. Oguma S. Banner B. Zerbe T. Starzl T. Demetris AJ: 
Participation of dendritic cells in vascular lesions of 
chronic rejection of human allografts. Lancet 1988, 
2:933-936 
2. Demetris AJ. Zerbe T. Banner B: Morphology of solid 
organ allograft arteriopathy: identification of proliferat-
ing intimal cell populations. Transplant Proc 1989. 21: 
3667-3669 
3. Hayry P, Isoniemi H. Yilmaz S. Mennander A, Lemstrom 
K. Raisanen-Solokowski A, Koskinen P, Ustinov J: 
Chronic allograft rejection. Immunol Rev 1993, 134: 
33-81 
4. Paul LC: Immunobiology of chronic renal transplant 
rejection. Blood Purification 1995, 13:206-218 
5. Adams DH, Russell ME, Hancock WW. Sayegh MH. 
_Wyner LA. Karnovsky MJ: Chronic rejection in experi-
mental cardiac transplantation: studies in the Lewis-
F344 model. Immunol Rev 1993, 134:5-19 
6. Cramer DV, Qian SQ, Harnaha J, Chapman FA, Estes 
LW, Starzl TE, Makowka L: Cardiac transplantation in 
the rat. I. The effect of histocompatibility differences 
on graft arteriosclerosis. Transplantation 1989, 47: 
414-419 
7. van Saase JL, van der Woude FJ, Thorogood J, Hol-
lander AA. van Es LA. Weening JJ. van Boekel JH. 
Bruijn JA: The relation between acute vascular and 
interstitial renal allograft rejection and subsequent 
chronic rejection. Transplantation 1995,59:1280-1285 
8. Billingham ME: Pathology and etiology of chronic re-
jection of the heart. Clin Transplant 1994, 8:289-292 
9. Yousem SA. Paradis IL. Dauber JH. Zeevi A, Du-
quesnoy RJ. DalCol R. Armitage J. Hardesty J, Griffith 
BP: Pulmonary arteriosclerosis in long-term human 
heart-lung transplant recipients. Transplantation 1989, 
47:564-569 
10. Tullius SG. Hancock WW. Heemann U. Azuma H. Til-
ney NL: Reversibility of chronic renal allograft rejection: 
critical effect of time after transplantation suggests 
both host immune dependent and independent phases 
of progressive injury. Transplantation 1994.58:93-99 
11. Starzl TE, Demetris AJ. Murase N. IIdstad S, Ricordi C. 
Trucco M: Cell migration. chimerism, and graft accep-
tance. Lancet 1992. 339:1579-1582 
12. Starzl TE. Demetris AJ: Transplantation milestones: 
viewed with one- and two-way paradigms of tolerance. 
JAMA 1995. 273:876-879 
13. Demetris AJ, Murase N, Starzl TE: Donor dendritic cells 
after liver and heart allotransplantation under short-
term immunosuppression. Lancet 1992. 339:1610 
14. Demetris AJ, Murase N. Delaney CPo Woan M. Fung JJ. 
Starzl TE: The liver allograft. chronic (ductopenic) re-
jection, and microchimerism: what can they teach us? 
Transplant Proc 1995,27:67-70 
15. Reinsmoen NL, Jackson A, McSherry C, Ninova D. 
Wiesner Rh, Kondo M, Krom RAF. Hertz MI. Bolman 
RM, Matas AJ: Organ-specific patterns of donor anti-
gen-specific hyporeactivity and peripheral blood allo-
geneic microchimerism in lung, kidney, and liver reCip-
ients. Transplantation 1995. 60:1546-1554 
16. Owen RD: Immunogenetic consequences of vascular 
anastomoses between bovine twins. Science 1945, 
102:400-401 
" 
17. Billingham RE. Brent L. Medawar PB: Actively acquired 
toleranee of foreign cells. Nature 1953. 172:603-606 
18. Billingham R, Brent L. Medawar P: Quantitative studies 
on tissue transplantation immunity. III. Actively ac-
quired tolerance. Philos Trans R Soc Lond (Bioi) 1956, 
239:357-412 
19. Main JM, Prehn RT: Successful skin homografts after 
the administration of high dosage X radiation and ho-
mologous bone marrow. J Natl Cancer Inst 1955, 15: 
1023-1029 
20. IIdstad ST. Sachs DH: Reconstitution with syngeneic 
plus allogeneic or xenogeneic bone marrow leads to 
~ specific acceptance of allografts or xenografts. Nature 
1984.307:168-170 
21. Bushell A, Pearson TC, Morris PJ, Wood KJ: Donor-
recipient microchimerism is not required for tolerance 
induction following recipient pretreatment with donor-
specific transfusion and anti-CD4 antibody. Transplan-
tation 1995,59:1367-1371 
22. Shirwan H, Wang HK, Barwari L, Makowka L, Cramer 
DV: Pretransplant injection of allograft reCipients with 
donor blood or lymphocytes permits allograft tolerance 
without the presence of persistent donor microchimer-
ism. Transplantation 1996.61:1382-1386 
23. Schlitt HJ, Hundrieser J, Hisanaga M, Uthoff K, Karck 
M, Wahlers T. Wonigeit K. Pichlmayr R: Patterns of 
donor-type microchimerism after heart transplantation. 
Lancet 1994, 343:1469-1471 
24 Murase N, Starzl TE, Tanabe M, Fujisaka S, Miyazawa 
H, Qing YE, Delaney CP, Demetris AJ: Variable chimer-
ism, graft versus host disease, and tolerance after 'dif-
ferent kinds of cell and whole organ transplantation 
from Lewis to Brown-Norway rats. Transplantation 
1995,60:158-171 
25. Kamada N, Caine RY: Orthotopic liver transplantation 
in the rat. technique using cuff for portal vein ana$)-
mosls and biliary drainage. Transplantation 1979, 28: 
47-50 
26. Ono K, Lindsey ES: Improved technique of heart trans-
plantation in rats. J Thorac Cardlovasc Surg 1969, 
7225-229 
27. Demetris A, Oian S. Sun H, Fung JJ, Yagihashi A, 
Murase N, Iwaki y, Gambrell B, Starzl TE Early events 
in liver allograft rejection: delineation of sites of simul-
taneous intragraft and recipient lymphoid tissue sensi-
tization. Am J Pathol 1991. 138609 
28. Yagihashi A, Takahashi S, Murase N. Starzl TE, Iwaki 
Y: A monoclonal antibody (L21-6) recognizing an 
invariant chain expressed on the cell surface in rats 
with the exception of the BN (RT1n). a study of tissue 
and strain distribution. Transplant Proc 1995, 27: 
1519-1521. 
29. Qian S, Demetris AJ, Murase N, Rao AS. Fung JJ, Starzl 
TE: Murine liver allograft transplantation: tolerance and 
donor cell chimerism. Hepatology 1994, 19:916-924 
30. Kalo S, Yasunaga A, Uchida U: Enzyme-histochemical 
method for identification of lymphatic capillaries. Lym-
phology 1991, 24:125-129 
31. Werner JA, Schunke M, Tillmann B: Histochemical vi-
sualization of lymphatic capillaries in the rat: a compar-
ison of methods demonstrated at the posterior pharyn-
geal surface. Arch Histol Jpn 1987, 50:505-514 
32. Chirgwin JM, Przybyla AE, Macdonald RJ, Rutter WJ: 
Isolation of biologically active ribonucleic acid from 
Sources enriched in ribonuclease. Biochemistry 1979, 
185294 
33. Brenner CA, Tam AW, Nelson PA: Message amplifica-
tion phenotyping (MAPPing): a technique to simulta-
neously measure multiple mRNAs from small number 
of cells. Blotechniques 1989, 71096 
34. Keenan RJ, Zeevi A. Iacono AT, Spichty KJ, Yousem 
SA, Ohori PN, Paradis IL, Griffith BP Efficacy of inhaled 
cyclosporine In lung transplant patients with refractory 
rejection' correlation of intragraft cytokine gene ex-
pression with pulmonary function and histology. Sur-
gery 1995.118385-391 
35. Billingham ME: Cardiac transplantation. The Pathology 
of Organ Transplantation. Edited by GE Sale. Boston 
Butterworths. 1990,133-152 
36. Lu L, Rudert WA. Qlan S. McCaslin D. Fu F, Rao AS. 
Trucco M, Fung JJ. Starzl TE, Thomson AW: Growth of 
donor-derived dendritic cells from the bone marrow of 
murine liver allograft recipients in response to granulo-
Chronic Rejection and Obliterative Arteriopathy 577 
AJP Febntary 1997, Vol. 150. No.2 
cyte/macrophage colony-stimulating factor. J Exp Med 
1995, 182:379-387 
37. Solti F, Jellinek H, Schneider F, Lengyel E, Berczi V, 
Kekesi V: Lymphatic arteriopathy: damage to the wall 
Gf the canine femoral artery after lymphatic blockade. 
Lymphology 1991, 24:54-59 
38. Matzinger P: Tolerance, danger, and the extended 
family. Annu Rev Immunol 1994, 12:991-1045 
39. Bertolino P, Heath WR, Hardy CL, Morahan G, Miller JF 
Peripheral deletion of autoreactive CD8+ T cells in 
transgenic mice expressing H-2Kb in the liver: EU! __ ~_ 
J Immunol 1995,25:1932-1942 
40. Chen-Woan M, Delaney CP, Fournier V, Wakizaka Y, 
Murase N, Fung JJ, Starzl TE. Demetris AJ: In vitro 
characterization of rat bone marrow-derived dendritic 
cells and their precursors. J Leukocyte Bioi 1996, 59 
196-206 
41. Murase N, Starzl TE, Ye Q, Tsamandas T, Thomson 
AW, Rao AS, Demetris AJ: Multilineage hematopoi-
etic reconstitution of supralethally irradiated rats by 
syngeneic whole organ transplantation. with particu-
lar reference to the liver. Transplantation 1996, 61. 
1-4 
42. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H: Pres-
ence of hematopoietic stem cells in the adult liver. 
Nature Med 1996,2:198-203 
43. Maeda T, Eto M, Nishimura Y. Nomoto K, Kong yy, 
Nomoto K: Role of peripheral hemopoietic chimerism in 
achieving donor-specific tolerance In adult mice. J Im-
munol 1993, 50753-762 
44. Arnold B, Schonrich G, Hammerling GJ: Multiple levels 
of peripheral tolerance. Immunol Today 1993, 14: 
12-14 
45. Schonrich G, Alferink J, Klevenz A. Kublbeck G, Au-
phan N, Schmitt-Verhulst AM, Hammerling GJ, Arnold 
B: Tolerance induction as a multi-step process. Eur 
J Immunol 1994,24:285-293 
46. Billingham R, Brent L: Quantitative studies on trans-
plantation immunity. IV. Induction of tolerance in new-
born mice and studi"s on the phenomenon of runt 
disease. Philos Tram R Soc Lond (Bioi) 1956, 242: 
439-477 
47. Malek P, Vrubel J, Kolc J: Lymphatic aspects of exper-
imental and clinical renal transplantation. Bull Soc Int 
Chirurgie 1969,28:110-114 
48. Malek P. Vrubel J: Lymphatic system and organ trans-
plantation. Lymphology 1968, 1:4-22 
49. Cockett AT, Sakai A, Netto IC: Kidney lymphatics an 
important network in transplantation. Trans Am Assoc 
Genito Urinary Surg 1973. 6573-76 
50. Eliska 0, Eliskova M. Mlrejovsky P: Lymph vessels of 
the transplanted kidney. Nephron 1986,44136-141 
51. Ruggiero R, Fietsam R, Jr., Thomas GA, Muz J, Farris 
RH. Kowal TA. Myles JL. Stephenson LW, BaciewlczFA 
Jr: Detection of canine allograft lung rejection by pul-
monary Iymphosclntigraphy. J Thorac Cardiovasc Surg 
1994, 108253-258 
1 
.-
; !I 
-' • : 'I .. .1 t r #  
" ; 
. ' 
.} v) ~Kg nl :::;;: :~;; ?~ 
(' ) 
f,. .. ·i 
cr 
'"'0 
~ 
__ , C', 
1ft .,' 
(0 (::: . 
?:I i'l 
,.') ;.c '-
'1:' 
f:~; 
-. I~-
578 Demetris et al 
AJP Fl'hruar:.v 1997, vol. 150, No.2 
52. Schmld-Schonbein GW: Microlymphatlcs and lymph 
flow. Physiol Rev 1990, 70:987-1028 
53. Billingham ME: The postsurgical heart. Am J Cardio-
vasc Pathol1988, 1:319-334 
54. Costanzo-Nordin MR, Winters GL, Fisher SG, 
O'Sullivan J, Heroux AL, Kao W. Mullen GM. Johnson 
MR: Endocardial infiltrates in the transplanted heart. 
J Heart Lung Transplant 1993, 12:741-747 
55 Kottke-Marchant K, Ratliff NB Endomyocardial lym-
phocytic infiltrates in cardiac transplant recipients. 
Arch Pathol Lab Med 1989. 113:690-698 
56 Radio SJ. McManus BM, Winters GL. Kendall TJ, 
Wilson JE. Costanzo-Nordin MR. Ye Y: Preferential 
endocardial residence of B-cells in the "Quilty effect" 
of human heart allografts immunohistochemical 
distinction from rejection Mod Pathol 1991. 4: 
654-660 
57. Mosnier JF, Oegott C, Marcellin P, Henin O. Erlinger S, 
BenhamolJ JP: The intraportal lymphoid nodule and its 
environment in chronic active hepatitis. Hepatology 
1993, 17:366-371 
58. Kemnitz J. Cohnert T, Schafters H. Helmke M. Herr-
mann G, Schmidt RM. Haveflch A A classification of 
cardiac allograft rejection. Am J Surg Pathol 1987. 
11 :503-515 
59. Forbes ROC, Rowan RA, Billingham ME: Endocardial 
infiltrates in human heart transplants: a serial biopsy 
analysis comparing four Immunosuppression proto-
cols. Hum Pathol 1990.21850-855 
60, Kemnitz J, Cremer J. Schaefers H. Restrepo-Specht 
I. Haverich A, Ulysal A. Heublein 8. Wirth S: Some 
aspects of changed histopathologic appearance of 
acute rejection in cardiac allografts after prophylac-
tic application of OKT3. J Heart Lung Transplant 
1991. 10366-372 
61, Pardo-Mindan FJ. Lozano MD. Contreras-Mejuto F. 
deAlava E Pathology of 'leart transplant through en-
domyocardial biopsy. Semin Oiagn Pathol 1992. 
9238-248 
62. Joshi A. Masek MA. Brown BWJ. Weiss LM, Billingham 
ME: "Quilty" revisited a 10-year perspective. Hum 
Pathol 1995, 26547-557 
j 
